Jonathan Daniel/Getty Images
One of the biggest surprise stories of the first half of the 2012 season, Melky Cabrera entered the All-Star break hitting .353 and captured MVP honors in the Midsummer Classic.
However, his breakout season came to a screeching halt when he earned a 50-game suspension for a positive PED test.
Set to cash in on a major payday, the positive test could not have come at a worse time for Cabrera, and he entered the offseason hoping someone would take a chance on him.
The Blue Jays turned out to be that someone, and while it was a solid risk/reward move for them, this is not quite the move-of-the-offseason type steal that some have made it out to be.
No one knows exactly when Cabrera began using PEDs, but entering the 2011 season he was putting up an average season of .267 BA, 7 HR, 45 RBI before taking a big step forward in 2011 and then another last season.
A one-year deal would have been a far safer move for the Blue Jays, and if he reverts to his pre-2011 form as he very well could, the team has a very expensive fourth outfielder on their hands.